Company profile: Vyasa
1.1 - Company Overview
Company description
- Provider of an AI-powered platform for life sciences and healthcare organizations, enabling businesses to integrate and analyze data across cloud and on-premise sources into a unified data platform. Offers Certara.AI, a secure platform for deploying life science-specific GPTs with real-time indexing of organizational data for drug development, clinical trials, and regulatory submission.
Products and services
- Vyasa Analytics AI Platform: A novel AI-powered system that allows businesses to integrate and analyze content across their entire data landscape, producing unified insights across life sciences and healthcare datasets
- Vyasa Layar: Connects to both cloud and on-premise data sources, constructing a unified data platform that organizations can explore for integrated content analysis
- Certara.AI: A secure platform for deploying life science-specific GPTs, delivering real-time indexing of organizational data for drug development, clinical trials, and regulatory submission activities
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Vyasa
SchrΓΆdinger
HQ: United States
Website
- Description: Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full SchrΓΆdinger company profile β
Cellworks
HQ: United States
Website
- Description: Provider of life sciences technology for drug and bio-marker discovery and research in therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cellworks company profile β
Invivodata
HQ: United States
Website
- Description: Provider of electronic patient-reported outcomes (ePRO) solutions and services for clinical trials, offering patient data collection, data management, and clinical outcome assessments software. Offers DiaryPRO electronic patient diary and DiaryPRO Web for PRO data collection via a web interface, and provides SitePRO, helping worldwide clinical trial sponsors assess the effectiveness of new medical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Invivodata company profile β
Omnyx
HQ: United States
Website
- Description: Provider of digital pathology solutions for hospital anatomic pathologists, including image acquisition devices and workflow software. The Omnyx IDP solution enables pathology departments worldwide to move to an all-digital workflow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Omnyx company profile β
Author-it
HQ: United States
Website
- Description: Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Author-it company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Vyasa
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vyasa
2.2 - Growth funds investing in similar companies to Vyasa
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Vyasa
4.2 - Public trading comparable groups for Vyasa
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β